Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case–control study
Maryrose Bauschka, Ashlie Watters, Dan Blalock, Asma Farooq, Philip Mehler, Dennis Gibson · 2023
Read Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case–control study by Maryrose Bauschka, Ashlie Watters, Dan Blalock, Asma Farooq, Philip Mehler, Dennis Gibson (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10699020.txt.
Description
Maryrose Bauschka and co-authors present a 2023 study on a fear that can block treatment in severe anorexia. Atypical antipsychotic drugs sometimes help the anxiety and distorted thinking of the illness, but in other patients they reliably cause weight gain, which terrifies people with anorexia. No drug is approved for the condition, so every option carries this tension.
The team reviewed records of patients with extreme anorexia in a case-control design. Their hypothesis was that this group, unlike other psychiatric patients, does not gain extra weight from these drugs. The comparison bore that out: weight restoration proceeded at the same pace with or without the medication. The finding may ease a hard conversation at the bedside. Clinicians can offer symptom relief without promising a side effect that does not appear.
Catalog record
| CREATOR | Maryrose Bauschka, Ashlie Watters, Dan Blalock, Asma Farooq, Philip Mehler, Dennis Gibson |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |